Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells

Anti-Cancer Drugs

Volumn 19, Issue 8, 2008, Pages 783-788

  Gilbert, Jennifer L ^a,b   Purcell, James ^a,b   Strappe, Padraig ^b   McCabe, Matthew ^a   OBrien, Timothy ^b   ODea, Shirley ^a,b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adeno associated virus; Lipofection; Lung cancer; Particle bombardment

Indexed keywords

ADENOASSOCIATED VIRUS 2 VECTOR; ADENOASSOCIATED VIRUS 5 VECTOR; ADENOASSOCIATED VIRUS 6 VECTOR; EFFECTENE; GENE THERAPY AGENT; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LIPOFECTAMINE; LIPOFECTAMINE 2000; PARVOVIRUS VECTOR; SUPERFECT; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; DRUG CARRIER; LIPID; LIPOSOME;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CELL TYPE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; FEMALE; GENE DELIVERY SYSTEM; GENE GUN; GENE TRANSFER; GENETIC TRANSFECTION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE MEDIATED GENE TRANSFER; PRIORITY JOURNAL; PSEUDOTYPING; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; BIOLISTIC TRANSFORMATION; C3H MOUSE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; ELECTROCHEMOTHERAPY; EPITHELIUM CELL; GENE VECTOR; GENETICS; LENTIVIRINAE; LUNG; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; VIRUS;

ADENOVIRIDAE; ANIMALS; BIOLISTICS; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DRUG CARRIERS; ELECTROCHEMOTHERAPY; EPITHELIAL CELLS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LENTIVIRUS; LIPIDS; LIPOSOMES; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; VIRUSES;

EID: 53749103782     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32830c432d     Document Type: Article

References (11)

1. Toloza EM, Morse MA, Lyerly HK. Gene therapy for lung cancer. J Cell Biochem 2006; 99:1-22.
2. Montier T, Delepine P, Pichon C, Ferec C, Porteous DJ, Midoux P. Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol 2004; 22:586-592.
3. Kolb M, Martin G, Medina M, Ask K, Gauldie J. Gene therapy for pulmonary diseases. Chest 2006; 130:879-884.
4. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 1990; 87:9568-9572.
5. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121:823-835.
6. McMahon JM, Conroy S, Lyons M, Greiser U, O'Shea C, Strappe P, et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 2006; 15:87-96.
7. Djurovic S, Iversen N, Jeansson S, Hoover F, Christensen G. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol 2004; 28:21-32.
8. Iversen N, Birkenes B, Torsdalen K, Djurovic S. Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells. Genet Vaccines Ther 2005; 3:2.
9. McBride S, Tatrai E, Blundell R, Kovacikova Z, Cardozo L, Adamis Z, et al. Characterisation of lectin binding patterns of mouse bronchiolar and rat alveolar epithelial cells in culture. Histochem J 2000; 32:33-40.
10. Seiler MP, Miller AD, Zabner J, Halbert CL. Adeno-associated virus types 5 and 6 use distinct receptors for cell entry. Hum Gene Ther 2006; 17:10-19.
11. Sumner-Jones SG, Davies LA, Varathalingam A, Gill DR, Hyde SC. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways. Gene Ther 2006; 13: 1703-1713.